Oncology
Taking chemotherapy directly to skin lesions, with Dr Raza B...
At BIO 2025 in Boston, editor-in-chief Jonah Comstock spoke with Dr Raza Bokhari, CEO of Medicus Pharma.
Oncology
Johnson & Johnson, ASCO 2025: Redefining global cancer care
Mark Wildgust, VP of global medical affairs, oncology, at Johnson & Johnson Innovative Medicine, discusses J&J’s ambition to get in front of cancer.
Digital
Chaos & opportunity: Dr Adam Brown unpacks US health policy
Dive into our video interview with Dr Adam Brown as he unpacks the chaos and opportunity shaping US health policy.
Oncology
Liver cancer diagnostic gets FDA breakthrough status, with P...
Mursla Bio CEO and founder Pierre Arséne discusses the breakthrough designation from the FDA for their blood test to catch liver cancer early.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks